Phase 3 Trial Demonstrates that MC2-01 Cream has Improved Treatment Efficacy Compared to Calcipotriene Plus Betamethasone Dipropionate Topical Suspension in Patients with Mild to Moderate Psoriasis Vulgaris. J of Skin [Internet]. 2020 Sep. 2 [cited 2026 May 7];4(5):s36. Available from: https://skin.dermsquared.com/skin/article/view/985